Real World Use of Emicizumab in Infants and Children Ages 0-3 Years With Hemophilia A

Recruiting

EmicizumabReal World Use of Emicizumab in Infants and Children Ages 0-3 Years With Hemophilia A

Sponsor:

Montefiore Medical Center

Code:

NCT05248594

Conditions

Hemophilia A

Eligibility Criteria

Sex: All

Age: 0 - 36

Healthy Volunteers: Not accepted

Interventions

HEMLIBRA

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-29. This information was provided to ClinicalTrials.gov by Montefiore Medical Center on 2025-02-03.